Malanil is a combination antimalarial tablet containing Atovaquone and Proguanil, formulated to treat and prevent malaria, especially infections caused by Plasmodium falciparum. It works by disrupting the parasite’s ability to replicate and produce energy, leading to rapid clearance of the infection from the bloodstream. Its dual‑action mechanism makes it a reliable choice for both treatment and prophylaxis in malaria‑endemic areas.

Uses:
Malanil Tablet is used for the treatment of acute uncomplicated malaria and for prevention of malaria in individuals traveling to or living in malaria‑prone regions. It helps reduce symptoms such as fever, chills, headache, sweating, nausea and fatigue, while also helping prevent the infection from establishing in the body.

Who Should Take It:
Malanil is suitable for adults and children (as per weight‑based dosing) who require treatment for confirmed malaria or protection against malaria during travel or residence in endemic areas. It should be taken exactly as prescribed by a healthcare professional.

Common Side Effects:
Common side effects may include headache, nausea, vomiting, abdominal discomfort, diarrhea, insomnia or mild dizziness. Rarely, it may cause liver enzyme changes or allergic reactions. If severe or persistent symptoms occur, medical advice should be sought.